Previous Close | 0.0000 |
Open | 0.0072 |
Bid | 0.0035 x 0 |
Ask | 0.0200 x 0 |
Day's Range | 0.0072 - 0.0072 |
52 Week Range | 0.0036 - 0.0400 |
Volume | |
Avg. Volume | 419 |
Market Cap | 5.099M |
Beta (5Y Monthly) | 0.55 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0000 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Toronto, Ontario--(Newsfile Corp. - September 12, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is providing this bi-weekly update on the status of its management cease trade order issued on August 29, 2024 (the "MCTO"), by its principal regulator, the British Columbia Securities Commission (the "BCSC"), under National Policy 12-203 Management Cease Trade Orders ("NP 12-203"). The Company announced on August 14, 2024 (the "Default Announcement"), that it expecte
Toronto, Ontario--(Newsfile Corp. - August 29, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that further to its release issued on August 14, 2024 in respect of its application to the British Columbia Securities Commission (the "BCSC") for a management cease trade order (the "MCTO"), that the BCSC has granted the MCTO, pursuant to which the Company will have until October 28, 2024 to file its annual audited ...
Toronto, Ontario--(Newsfile Corp. - August 23, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it intends to complete a non-brokered private placement offering (the "Offering") of up to 45,454,545 units ("Units"), at a price of $0.011 per Unit, for total gross proceeds of up to approximately $500,000.Each Unit will consist of one common share ("Share") and one half of one common share purchase warrant ("Warrant"). ...